Pre-clinical models of infectious diseases- therapeutic testing in murine models of bacterial infection
Ended Awarded Last action
- Contract number
- 75N93021F00002
- Awardee
-
Pharmacology Discovery Services Taiwan, LTD. UEI MXP1NVQ8C1J8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $952,930
Award facts
- Opportunity
-
- A58 Solicitation number
- Contract value 55% obligated
-
- $952,930.00 Current, with exercised options
- $1,747,930.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Taiwan
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$14,440 | |
| Exercise an Option | $132,550 | |
| Exercise an Option | $96,390 | |
| Original award | $738,430 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Pharmacology Discovery Services Taiwan, LTD. on August 10, 2021, with a ceiling value of $1.747930 million, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 IDIQ for preclinical models of bacterial infection and therapeutic testing in murine models.
The IDIQ supports development and supply of advanced animal models for screening and evaluating medical countermeasures including therapeutics, vaccines, and diagnostics. Place of performance is Taiwan. The order was administratively closed on August 9, 2022. Pricing is firm fixed price with no set-aside designation.
In fiscal year 2022, the order generated $953 thousand in government-invoiced labor, performed entirely by the prime with no subcontractors reported.
Quick answers
Who was awarded contract 75N93021F00002?
75N93021F00002 was awarded to Pharmacology Discovery Services Taiwan, LTD. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 10, 2021.
How much is contract 75N93021F00002 worth?
The government has obligated $952,930 on 75N93021F00002. Its potential value, with all options, is $1,747,930.
Is contract 75N93021F00002 an order under another contract?
Yes. 75N93021F00002 is a delivery order under HHSN272201700020I, an indefinite delivery contract, on NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract 75N93021F00002 competed?
The extent of competition for 75N93021F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award